CBD, Genetics, Pediatric Epilepsy, SUDEP
A round-up of the interesting and exciting epilepsy research news published in May 2019.
Seizure risk was nearly four times higher at nighttime festivals with the heavy-duty strobes than at daytime events, the researchers found.
This long-term follow-up over a 50-year life-span of persons who received childhood diagnoses of epilepsy suggests that the consequences for education, work, and leisure activities were few.
FutureNeuro and RCSI researchers have discovered molecules in the blood that are higher in people with epilepsy before a seizure happens. These molecules are fragments of transfer RNAs (tRNAs).
Study demonstrates clinical effectiveness of eslicarbazepine acetate, noting it is generally well tolerated as an adjunctive therapy in focal epilepsy patients with psychiatric comorbidities, including intellectual disability, compared with people with no psychiatric comorbidities.
Strategies aimed at improving the ability of principal neurons to maintain a trans-membrane chloride gradient in the face of excessive network activity can prevent interneurons from contributing to seizure perpetuation.
Compared to population norms, a high proportion of children of mothers with epilepsy exposed prenatally to monotherapy with four common antiepileptic drugs had clinical behavioral problems reported by parents.
The financial consequences of epilepsy among older Americans disproportionally affect minorities.
Children can keep full visual perception — the ability to process and understand visual information — after brain surgery for severe epilepsy, according to a study funded by the National Eye Institute (NEI), part of the National Institutes of Health.
